Spot on that we have AA patents in ours as well. Thanks for pointing that out Zuman. Nice find. To add to more good news with inflammatory markers, app 13/768869 just got NOA today.
This patent has all the regulars in its claims but also has claims for reducing lp-pla2 (an excellent marker and correlation on CVD risk and higher correlation than HsCRP in studies), reducing OXIDIZED LDL-C (the dangerous form if small particle LDL's that are oxidized leading to macro ingestion and foam cell formation causing plaques), and reducing HsCRP which is the more known marker that has been studied in the past and is still the front line test before the others mentioned are pursued.
Clear the direction we are heading by following the patents. Block upon block, line upon line. No definitive studies yet whether inflam markers are the causal or simply after effect of dz process but right now this is about the best preventative testing available to date.
Keep the good research coming folks and another Brick added to the thickness of the wall
News 
Market Data 
Discover 
